Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)
China flag China · Delayed Price · Currency is CNY
23.42
-0.26 (-1.10%)
At close: Feb 6, 2026

SHA:601567 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
15,03014,38411,2618,9396,9116,995
Other Revenue
216.26216.26201.71158.82112.3197.95
15,24714,60011,4639,0987,0237,093
Revenue Growth (YoY)
12.45%27.38%25.99%29.55%-0.98%4.22%
Cost of Revenue
10,8549,5847,6006,4875,2595,066
Gross Profit
4,3935,0173,8622,6111,7642,027
Selling, General & Admin
1,9861,9141,6261,188845.78771.53
Research & Development
524.54515.58463.77320.81285.94298.71
Other Operating Expenses
-96.7-71.8819.1123.3640.9222.41
Operating Expenses
2,4502,3822,1341,5221,2151,067
Operating Income
1,9432,6351,7291,089548.89959.69
Interest Expense
-109.99-95-52.75-61.33-83.25-28.45
Interest & Investment Income
279.14304.98342.58123.66239.61360.29
Currency Exchange Gain (Loss)
-111.94-111.9440.9255-32.97-79.98
Other Non Operating Income (Expenses)
156.36-31.01-30.67-17.4542.5-113.7
EBT Excluding Unusual Items
2,1572,7022,0291,189714.771,098
Impairment of Goodwill
-13.6-13.6-8.68-9.49-1.79-15.48
Gain (Loss) on Sale of Investments
52.99-177.13132.41-107.48103.765.38
Gain (Loss) on Sale of Assets
-0.45-0.04-0.1-1.88-7.65-4.9
Asset Writedown
-44.93-11.31-1.671.57-4.59-0.08
Other Unusual Items
183.99172.96111.4680.7842.3845.75
Pretax Income
2,3352,6732,2621,152846.811,189
Income Tax Expense
377.62399.32341.26187.04139.2227.65
Earnings From Continuing Operations
1,9572,2731,921965.01707.61960.88
Minority Interest in Earnings
14.4-13.72-17.1-16.89-17.57-4.76
Net Income
1,9722,2601,904948.12690.04956.12
Net Income to Common
1,9722,2601,904948.12690.04956.12
Net Income Growth
-11.59%18.69%100.79%37.40%-27.83%-4.81%
Shares Outstanding (Basic)
1,4181,4121,4101,4151,3801,386
Shares Outstanding (Diluted)
1,4181,4121,4101,4151,3801,386
Shares Change (YoY)
1.11%0.14%-0.35%2.54%-0.40%-0.67%
EPS (Basic)
1.391.601.350.670.500.69
EPS (Diluted)
1.391.601.350.670.500.69
EPS Growth
-12.56%18.52%101.49%34.00%-27.54%-4.17%
Free Cash Flow
323.12791.631,345818.7-96.31,024
Free Cash Flow Per Share
0.230.560.950.58-0.070.74
Dividend Per Share
1.3750.8900.6500.3500.3200.350
Dividend Growth
111.54%36.92%85.71%9.38%-8.57%66.67%
Gross Margin
28.81%34.36%33.69%28.70%25.11%28.57%
Operating Margin
12.75%18.05%15.08%11.97%7.82%13.53%
Profit Margin
12.93%15.48%16.61%10.42%9.83%13.48%
Free Cash Flow Margin
2.12%5.42%11.74%9.00%-1.37%14.44%
EBITDA
2,2192,9011,9811,317744.11,147
EBITDA Margin
14.56%19.87%17.29%14.48%10.60%16.17%
D&A For EBITDA
276.04266.07252.77228.7195.22187.11
EBIT
1,9432,6351,7291,089548.89959.69
EBIT Margin
12.75%18.05%15.08%11.97%7.82%13.53%
Effective Tax Rate
16.17%14.94%15.09%16.23%16.44%19.15%
Revenue as Reported
15,24714,60011,4639,0987,0237,093
Advertising Expenses
-32.2118.0711.288.047.54
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.